Market News & Trends
AureoGen Announces Licensing Agreement With Merck
AureoGen Biosciences Inc. recently announced a licensing agreement with Merck for the use of AureoGen's proprietary chemistry and compounds for the development of medicines for…
JDRF & Sanofi USAnnounce Expansion of Collaboration
JDRF and Sanofi US Services Inc., a subsidiary of Sanofi, have entered into new agreements with four research organizations under their joint research collaboration to…
Retrophin Receives European Orphan Drug Designation
Retrophin, Inc. recently announced the European Commission has granted orphan drug designation to RE-024, the company’s novel investigational phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration…
Rani Therapeutics Completes Latest Round of Funding; Brings Total Investment to $70 Million
Rani Therapeutics recently announced it has closed its latest round of funding, bringing the company's total investment to more than $70 million. New investors include…
West Appoints Eric Resnick to Chief Technology Officer
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently announced Eric Resnick has been appointed to serve as…
PolyPid Announces Completion of $22-Million Financing
PolyPid Ltd. recently announced it closed a $22-million private equity financing. The financing was co-led by new investor Shavit Capital and current investor Aurum Ventures.…
Codexis Files Major Lawsuit Against EnzymeWorks
Codexis, Inc. recently announced the filing of a lawsuit against EnzymeWorks and its founder, Junhua “Alex” Tao, for willful patent infringement, misappropriation of trade secrets,…
ICIG to Acquire All Shares in Sandoz Industrial Products
International Chemical Investors Group (ICIG) and Novartis Group have entered into an agreement under which ICIG will acquire all of the shares in Sandoz Industrial…
How the Need for an Alternative Oral Dosage Form Delivered a Patient-Centric Drug Formulation
Dysphagia can affect many people throughout their lifetime. It also represents a challenge for oral drug manufacturers. Dysphagia not only impacts patients’ ability to take…
Unilife & Amgen Enter Strategic Collaboration for Injectable Drug Delivery Systems; Amgen to Invest up to $75 Million
Unilife Corporation recently announced a strategic collaboration with Amgen for injectable drug delivery systems. The collaboration, which includes licensing, investment, development, and supply agreement components,…
First Prescription Drug Reaches European Market With Advancia
Six months after the successful industrialization of Nemera’s next-generation nasal spray pump, Advancia is on the European market with an intranasal corticosteroid suspension treating allergic…
Protea Announces Collaborative Partnership With Protein Metrics
Protea Biosciences Group, Inc. recently announced it is collaborating with Protein Metrics Inc., a premier provider of software solutions for the comprehensive characterization of proteins,…
Vetter Wins Two Coveted Awards for Syringe Closure System
The World Packaging Organization (WPO) has awarded Vetter the WorldStar Award 2016 for its syringe closure system Vetter-Ject. The WorldStar competition is one of the…
Inovio Pharmaceutical's DNA Vaccine for Zika Virus Induces Robust Immune Responses
Inovio Pharmaceuticals, Inc. recently announced that preclinical testing of its synthetic vaccine for the Zika virus induced robust and durable immune responses, demonstrating the potential…
Emergent BioSolutions’ Auto-Injector Platform Selected by US Department of Defense & Battelle
Emergent BioSolutions Inc. recently announced that Emergard, the company’s ruggedized, military-grade auto-injector platform, has been selected by the US Department of Defense (DoD) and Battelle…
Galapagos Starts SAPHIRA Phase II Study With GLPG1837 in Cystic Fibrosis Patients
Galapagos NV recently announced the first dosing in its Phase II exploratory program of GLPG1837 in patients with cystic fibrosis (CF). GLPG1837 is a candidate…
Hype Surrounding Cancer T-Cell Therapy Overlooks Safety & Cost Concerns
Although excitement surrounding recent trials of T-cell therapies and their ability to treat blood cancer has been widespread of late, there are lingering questions about…
Capsugel & Pulmatrix Enter Collaboration to Develop & Manufacture Novel Inhaled Therapeutics
Capsugel and Pulmatrix, Inc. have recently formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases. The agreement provides Capsugel exclusive rights…
VBI Vaccines Announces Vaccine Stability Collaboration With GlaxoSmithKline
VBI Vaccines Inc. has entered into a research collaboration with GlaxoSmithKline Biologicals SAto evaluate VBI’s LPV Platform, a proprietary formulation and process that enables the…
ZIOPHARM Announces First Patient Enrolled in Phase I Study; Drug Uses Sleeping Beauty Platform
ZIOPHARM Oncology, Inc. recently announced that the first patient has been enrolled in a Phase I clinical study of its second-generation non-viral CD19-specific chimeric antigen…